EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 8

Sage Salvia officinalis L.

Also called: common sage, sage leaf

Sage (Salvia officinalis) is a subshrub whose leaves are used as a culinary spice and in traditional remedies. Its essential oil contains thujone, which is toxic in large amounts, so EU regulators limit daily thujone exposure from sage medicines.

Category
Botanical
Part used
Leaf (as tea, extracts, tinctures); sage oil
Strongest evidence
C Limited
Native range
Native from southwest Germany to southern Europe (POWO: "SW. Germany to S. Europe")
Reviewed
2026-10-29

Class 2 Moderately studied in people. A 2023 systematic review and meta-analysis (Int J Community Based Nurs Midwifery) included 4 randomized trials (310 postmenopausal women) of oral Salvia officinalis extract alone for hot flashes, 3 versus placebo and 1 versus black cohosh. [3]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

6 topics studied4 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Sage does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Sage, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Menopausal hot flashesCNCCIH: a few small studies suggest common sage may reduce how often hot flashes occur. [2]
Hot flashes (pooled trials)CA meta-analysis of 4 trials (310 women) reported a pooled effect on hot-flash frequency of ES −1.12 (95% CI −2.37 to 0.14), which was not statistically significant, and no significant effect on severity. [3]
Memory and thinking in healthy peopleCNCCIH: a few studies suggest common sage, Spanish sage or both may improve memory or other thinking scores in healthy people; the evidence is small. [2]
Blood cholesterol and lipidsCNCCIH: a few studies suggest sage may benefit blood cholesterol and other lipids. [2]
Blood sugarCNCCIH: there is not enough evidence to show whether sage affects blood glucose. [2]
Blood sugar and lipids in diabetesCA meta-analysis of 3 trials in people with diabetes reported lower fasting glucose (−31.15 mg/dL) and HbA1c (−0.94%); the authors called for stronger trials because so few exist. [4]

Main constituents: Tannins (salviatannin); essential oil with alpha- and beta-thujone, 1,8-cineole and camphor; flavones, phenolic acids, phenylpropanoid glycosides, triterpenoids and diterpenes [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Stated in a regulatory monograph (EU, EMA HMPC, 2016), traditional use in mild dyspeptic complaints, adults: herbal tea of 1–2 g leaf in 150 ml boiling water 3 times daily, or dry extract (DER 4–7:1) 320 mg daily in 3–4 doses. [5]
  • NCCIH: larger-than-food amounts have been used safely for up to 8 weeks in studies. [2]

Upper limits

  • EU (EMA HMPC monograph, 2016): the amount of thujone has to be specified in the product, and daily thujone exposure has to be below 6.0 mg. [5]
Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    EU monograph (2016): safety during pregnancy and lactation has not been established; use is not recommended.

    3 statements in the profile.

    Details and sources
  • Interactions with medicines
    None reported

    Medicines in general: EU monograph (EMA HMPC, 2016), section 4.5: none reported.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked. The profile notes other test results.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    2 statements

    EU (EMA HMPC monograph, 20 September 2016), traditional use, adults: mild dyspeptic complaints — tea of 1–2 g leaf in 150 ml boiling water 3 times …

    Details and sources
  • Common sage contains thujone, which can be toxic in large amounts; sage may be unsafe in high doses or with long-term use (NCCIH). [2]
  • Intake of sage oil corresponding to more than 15 g of sage leaf is reported to cause a sensation of heat, rapid heartbeat, vertigo and seizures (EU monograph). [5]
  • Sage may be unsafe in pregnancy because of thujone; little is known about safety during breastfeeding (NCCIH). [2]
  • Sage is generally well tolerated, with occasional nausea, vomiting, abdominal pain, dizziness, agitation and wheezing; thujone and camphor are neurotoxic in high doses (LactMed). [1]
  • Sage likely is safe in amounts commonly found in food (NCCIH). [2]
Quality

Identity, quality and standardization

  • Sage is often misidentified and adulterated; Salvia bertolonii or Salvia pratensis are sometimes used instead of Salvia officinalis (LactMed). [1]
  • Thujone is reported to be neurotoxic, so the EU monograph says chemotypes with low thujone content should be preferred; material complies with the Ph. Eur. monograph (ref. 1370). [5]
Regulation

Regulatory status

  • US: No NDI notification naming sage (Salvia officinalis) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [6]
  • EU: EMA's HMPC monograph (2016) recognizes traditional use of sage leaf for mild dyspeptic complaints, excessive sweating, inflammations in the mouth or throat, and minor skin inflammations. [5]
  • US food use: 21 CFR 182.10 lists sage (Salvia officinalis L.) among spices and natural seasonings generally recognized as safe for their intended use. [7]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • alpha- and beta-Thujone, 1,8-cineole and camphor (essential oil) Monoterpenes (essential oil) [P1]
  • Tannins (salviatannin) Polyphenols (tannins) [P1]
  • Flavones and phenolic acids Flavonoids and phenolic acids [P1]
  • Triterpenoids and diterpenes Terpenoids [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming sage (Salvia officinalis) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
  • Food use: 21 CFR 182.10 (spices and other natural seasonings and flavorings) lists sage (Salvia officinalis L.) as generally recognized as safe for its intended use. [P3]
  • Food use: 21 CFR 182.20 (essential oils, oleoresins and natural extractives) lists sage (Salvia officinalis L.) as generally recognized as safe for its intended use. [P4]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of sage (Salvia officinalis) itself was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P5]
  • NTP TR 570 (2011) tested alpha,beta-thujone, a component of sage oil, by gavage for 2 years: it caused preputial gland cancers in male rats, and an increase in adrenal gland tumors in male rats may have been related to it; there was no increase in cancer in female rats or in mice. Seizures occurred at the highest doses. [P6]
  • EU monograph: adequate tests on genotoxicity and carcinogenicity of sage leaf have not been performed. [P7]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • Medicines in general: EU monograph (EMA HMPC, 2016), section 4.5: none reported. [P7]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • LactMed: sage is often misidentified and adulterated; Salvia bertolonii or Salvia pratensis are sometimes used instead of, or as an adulterant of, Salvia officinalis. [P1]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test of each dietary-ingredient lot (at least one appropriate test or examination) — Required for any component that is a dietary ingredient under 21 CFR 111.75(a)(1)(i), unless FDA grants a petition exemption. [P8]
  • Species identity distinguishing Salvia officinalis from S. bertolonii and S. pratensis — Misidentification and substitution with these species are reported. [P1]
  • Thujone content — EU monograph: the amount of thujone has to be specified; daily exposure must be below 6.0 mg because thujone is neurotoxic. [P7]
  • Compliance with the Ph. Eur. monograph for sage leaf (ref. 1370) — The EU monograph defines the herbal substance by this Ph. Eur. monograph. [P7]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P9]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • EU (EMA HMPC monograph, 20 September 2016), traditional use, adults: mild dyspeptic complaints — tea of 1–2 g leaf in 150 ml boiling water 3 times daily, or dry extract (DER 4–7:1) 320 mg daily in 3–4 doses; excessive sweating — dry extract 80–160 mg 3 times daily. [P7]
  • EU (same monograph), mouth or throat inflammation: 2.5 g leaf in 100 ml boiling water as a warm gargle 3 times daily. Use under 18 years is not recommended. [P7]

Pregnancy and breastfeeding

  • EU monograph (2016): safety during pregnancy and lactation has not been established; use is not recommended. [P7]
  • NCCIH: sage may be unsafe in pregnancy because of thujone; little is known about safety during breastfeeding. [P10]
  • LactMed: sage and Salvia fruticosa are purported to reduce milk supply and have been used for weaning; no studies of this effect, and no safety data in nursing mothers or infants, were located. [P1]

Sources for this profile

  1. Drugs and Lactation Database (LactMed). Sage. National Institute of Child Health and Human Development (revised 2025-07-15; NBK501816; PMID 30000875), 2025-07-15. pubmed.ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. eCFR. 21 CFR 182.10 Spices and other natural seasonings and flavorings (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
  4. eCFR. 21 CFR 182.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates) (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
  5. IARC Monographs. Agents Classified by the IARC Monographs, Volumes 1–142 (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  6. National Toxicology Program. Toxicology and carcinogenesis studies of alpha,beta-thujone (CAS No. 76231-76-0) in F344/N rats and B6C3F1 mice (gavage studies). NTP TR 570, 2011 (PMID 22127327), 2011-11. pubmed.ncbi.nlm.nih.gov
  7. European Medicines Agency (HMPC). European Union herbal monograph on Salvia officinalis L., folium. EMA/HMPC/277152/2015, Revision 1 (20 September 2016), 2016-09-20. ema.europa.eu
  8. eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
  9. GBIF species API: IUCN Red List category for Salvia officinalis, 2026-10-29. api.gbif.org
  10. NCCIH. Sage (last updated April 2025), 2025-04. nccih.nih.gov
Sources

Sources

  1. Drugs and Lactation Database (LactMed). Sage. National Institute of Child Health and Human Development (revised 2025-07-15; NBK501816; PMID 30000875), 2025-07-15. pubmed.ncbi.nlm.nih.gov
  2. NCCIH. Sage (last updated April 2025), 2025-04. nccih.nih.gov
  3. Moradi M, et al. The effect of Salvia officinalis on hot flashes in postmenopausal women: a systematic review and meta-analysis. Int J Community Based Nurs Midwifery 2023;11(3):169-178 (PMID 37489230), 2023-07. pubmed.ncbi.nlm.nih.gov
  4. Abdollahi A, et al. The effect of Salvia officinalis on blood glycemic indexes and blood lipid profile in diabetic patients: a systematic review and meta-analysis. J Complement Integr Med 2023;20(3):521-529 (PMID 35106985), 2023-09-01. pubmed.ncbi.nlm.nih.gov
  5. European Medicines Agency (HMPC). European Union herbal monograph on Salvia officinalis L., folium. EMA/HMPC/277152/2015, Revision 1 (20 September 2016), 2016-09-20. ema.europa.eu
  6. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  7. eCFR. 21 CFR 182.10 Spices and other natural seasonings and flavorings (text retrieved through the eCFR versioner API, version of 2026-09-01), 2026-09-01. ecfr.gov
  8. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Salvia officinalis L. (accessed 2026-10-29). powo.science.kew.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.